Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2632  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer’s Disease
Jimiece Thomas,Haddon Smith,C. Aaron Smith,Lori Coward,Gregory Gorman,Maria De Luca,Patricia Jumbo-Lucioni
Pathophysiology.2021;28(2)307
[DOI]
2Early Candidate Urine Biomarkers for Detecting Alzheimer’s Disease Before Amyloid-ß Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model
Fanshuang Zhang,Jing Wei,Xundou Li,Chao Ma,Youhe Gao
Journal of Alzheimer's Disease.2018;66(2)613
[DOI]
3A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice
Daniela Carmen Ababei,Veronica Bild,Alin Ciobica,Radu Marian Lefter,Razvan Nicolae Rusu,Walther Bild
American Journal of Alzheimer's Disease & Other Dementias®.2019;34(5)329
[DOI]
4A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice
Karlo Toljan,Jan Homolak
American Journal of Alzheimer's Disease & Other Dementias®.2021;179(5)285
[DOI]
5Neuropeptides in Alzheimer’s Disease: An Update
Carla Petrella,Maria Grazia Di Certo,Christian Barbato,Francesca Gabanella,Massimo Ralli,Antonio Greco,Roberta Possenti,Cinzia Severini
Current Alzheimer Research.2019;16(6)544
[DOI]
6Evaluation of antioxidant properties of angiotensinconverting enzyme inhibitors-interactions with free radicals model examined by EPR spectroscopy
Anna Juszczak,Pawel Ramos,Wojciech Szczolko,Barbara Pilawa,Beata Stanisz
Pharmacy & Pharmacology International Journal.2020;8(1)25
[DOI]
7Evaluation of antioxidant properties of angiotensinconverting enzyme inhibitors-interactions with free radicals model examined by EPR spectroscopy
Volkan Gelen,Abdulsamed Kükürt,Emin Sengül
Pharmacy & Pharmacology International Journal.2021;8(1)25
[DOI]
8Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats
Yahya M. Alzahrani,Mai A. Alim A. Sattar,Fatemah O. Kamel,Wafaa S. Ramadan,Yahya A. Alzahrani
Saudi Pharmaceutical Journal.2020;28(5)574
[DOI]
9Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease
Karim Fazal,Gayan Perera,Mizanur Khondoker,Robert Howard,Robert Stewart
BJPsych Open.2017;3(4)158
[DOI]
10COVID-19: ICU delirium management during SARS-CoV-2 pandemic
Katarzyna Kotfis,Shawniqua Williams Roberson,Jo Ellen Wilson,Wojciech Dabrowski,Brenda T. Pun,E. Wesley Ely
Critical Care.2020;24(1)158
[DOI]
11Antihypertensive Drugs and Risk of Depression
Lars Vedel Kessing,Helene Charlotte Rytgaard,Claus Thorn Ekstrøm,Christian Torp-Pedersen,Michael Berk,Thomas Alexander Gerds
Hypertension.2020;76(4)1263
[DOI]
12Antihypertensive Drugs and Risk of Depression
Kewal K. Jain
Hypertension.2019;76(4)465
[DOI]
13Use of ACE-inhibitors and Quality of Life in an Older Population
A. Laudisio,Silvia Giovannini,P. Finamore,A. Gemma,R. Bernabei,R. A. Incalzi,G. Zuccalà
The journal of nutrition, health & aging.2018;22(10)1162
[DOI]
14Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
Jessika Royea,Edith Hamel
GeroScience.2020;42(5)1237
[DOI]
15Role of brain renin angiotensin system in neurodegeneration: An update
Oyesiji A. Abiodun,Mohammad Shamsul Ola
Saudi Journal of Biological Sciences.2020;27(3)905
[DOI]
16Angiotensin-(1-7) and Mas receptor in the brain
Natalia L. Rukavina Mikusic,Angélica M. Pineda,Mariela M. Gironacci
Exploration of Medicine.2021;2(3)268
[DOI]
17The depressor axis of the renin–angiotensin system and brain disorders: a translational approach
Mariela M. Gironacci,Augusto Vicario,Gustavo Cerezo,Mauro G. Silva
Clinical Science.2018;132(10)1021
[DOI]
18Long non-coding RNA and mRNA analysis of Ang II-induced neuronal dysfunction
Lin-Lin Shao,Yue-Hua Jiang,Ling-Yu Jiang,Chuan-Hua Yang,Ying-Zi Qi
Molecular Biology Reports.2019;46(3)3233
[DOI]
19Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Steven J. Forrester,George W. Booz,Curt D. Sigmund,Thomas M. Coffman,Tatsuo Kawai,Victor Rizzo,Rosario Scalia,Satoru Eguchi
Physiological Reviews.2018;98(3)1627
[DOI]
20Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention
Walaa Fakih,Ralph Zeitoun,Ibrahim AlZaim,Ali H. Eid,Firas Kobeissy,Khaled S. Abd-Elrahman,Ahmed F. El-Yazbi
Obesity.2022;30(5)982
[DOI]
21Contemporary methods of improving cognitive dysfunction in clinical depression
Matthew J. Knight,Natalie T. Mills,Bernhard T. Baune
Expert Review of Neurotherapeutics.2019;19(5)431
[DOI]
22Contemporary methods of improving cognitive dysfunction in clinical depression
Arunachalam Muthuraman,Narahari Rishitha,Johurul Islam
Expert Review of Neurotherapeutics.2019;19(5)431
[DOI]
23Comprehensive Proteomic Profiling of Urinary Exosomes and Identification of Potential Non-invasive Early Biomarkers of Alzheimer’s Disease in 5XFAD Mouse Model
Zhiqi Song,Yanfeng Xu,Ling Zhang,Li Zhou,Yu Zhang,Yunlin Han,Xianglei Li,Pin Yu,Yajin Qu,Wenjie Zhao,Chuan Qin
Frontiers in Genetics.2020;11(5)431
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow